Ppar Gamma Agonists: An Effective Strategy for Cancer Treatment

Journal of Pharmaceutical and Scientific Innovation
doi 10.7897/2277-4572.02575
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moksha Publishing House

Related search

PPAR Agonists: Potential as Therapeutics for Neovascular Retinopathies

PPAR Research
Drug DiscoveryPharmacology
2008English

PPAR Agonists and Cardiovascular Disease in Diabetes

PPAR Research
Drug DiscoveryPharmacology
2008English

Differential Antiatherogenic Effects of PPAR Versus PPAR Agonists: Should We Be Surprised?

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2005English

Oral Piritrexim, an Effective Treatment for Metastatic Urothelial Cancer

British Journal of Cancer
Cancer ResearchOncology
1993English

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

PPAR Research
Drug DiscoveryPharmacology
2008English

Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase a Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer

Cancers
Cancer ResearchOncology
2019English

PPAR Ligands for Cancer Chemoprevention

PPAR Research
Drug DiscoveryPharmacology
2008English

Structural Basis for Telmisartan-Mediated Partial Activation of PPAR Gamma

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2012English

Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy